Neurosciences articles for China

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 398

Article ‘Count’ for Neurosciences.

Journal Count Share
23 22.84
Inhibition of Pain Signal Conduction in Dorsal Root Ganglion Neurons by Optogenetic Technique Mediated with Upconversion Nanoparticles 1.00
Neuroimmune-Metabolic Regulation by a Wireless Biodegradable Neuromodulator for Cardiovascular Therapy in a Mouse Model 1.00
Chloroplast-Inspired Nanoassemblies for Ischemic Stroke Therapy: Cross-Kingdom Recoupling with Mitochondrial Metabolism 1.00
Probiotic Spore-Based Oral Biotherapeutics Promote Brain Targeting toward Gut-Brain Dual-Regulation for Parkinson’s Disease Treatment 1.00
Bioinspired Multilayered Conductive Nerve Guidance Conduit Built on Hydrogels and Knitted Silk Fiber Sleeves for Peripheral Nerve Regeneration 1.00
A Preventable Alzheimer’s Disease Microneedle Patch with Synaptic Protection and NLRP3 Inflammasome Suppression in Microglia during Smoking Cessation 1.00
Neonatal Spinal-Cord-Like Scaffold with Hierarchical Structural and Neurogenetic Microenvironments for Spinal Cord Injury Repair 1.00
Amphiphilic Ebselen Conjugate Suppresses Tripartite Motif-Containing 21-Glutathione Peroxidase 4 Axis-Dependent Neuronal Ferroptosis and Ameliorates Epilepsy 1.00
Meningeal Lymphatic System-Driven Nanodelivery Unlocks Ursolic Acid’s Pleiotropic Benefits To Optimize Multiple Sclerosis Treatment 1.00
Rabies Virus Glycoprotein-Decorated Liposomes in Thermosensitive Nasal Spray Gels: Facilitating Retrograde Neural Transport for Targeted Trigeminal Neuralgia Therapy 1.00
Small Gold Nanoparticles Alleviate Huntington’s Disease via Modulating p38α Mitogen-Activated Protein Kinase and Pyruvate Dehydrogenase Kinase 1 1.00
Piezo1-Targeted Magnetoacoustic Nanobubbles Rescue Alzheimer’s Pathology by Electromechanical Neuromodulation and Amyloid-β Clearance 1.00
An Autophagy-Sensitive Nanoplatform via Chirality-Selective Modulation for Functional Peripheral Nerve Repair and Target Organ Homeostasis 0.94
Unlocking Neuroprotection: Simultaneous Suppression of Mitochondrial Energetic Collapse and Oxidative-Inflammatory Vortex for Ischemia-Reperfusion Brain Injury 1.00
Modulating Amyloid Pathology–Neural Hyperexcitability Crosstalk for Alzheimer’s Disease Therapy 1.00
Piezo-Nanowired Stem Cells: Ultrasound-Powered Neuronal Commitment for Rapid Neural Circuit Reconstruction after Traumatic Brain Injury 1.00
Engineering Near-Infrared-II Nanoprobes Reveal Dexmedetomidine Potentiating Brain Waste Clearance in Healthy and Sleep-Restricted Mice 1.00
Hybrid Exosome–Liposome Nanoparticles for Dual Modulation of Neuroinflammation and Lipid Metabolism in Ischemic Stroke 1.00
Biomimetic Nanoregulators Mediated Tyrosine Hydroxylase mRNA and Stimulator of Interferon Genes Antagonist Codelivery for Synergistic Therapy on Parkinson’s Disease 1.00
An Implant-Free Nanosystem Enabling Synergistic Oxidative Damage Mitigation and Deep Brain Stimulation for Alleviating Parkinsonian Symptoms 1.00
Inflammatory Oriented Nanospheres-Reconstructed Extracellular Matrix in Ischemic Stroke 1.00
Triple-Cue-Guided Multichannel Hydrogel Conduit to Synergistically Enhance Peripheral Nerve Repair 0.89
Mesenchymal Stem Cell-Derived Mitochondrial Transfer Promotes Tip Cell Phenotype via Glutathione Metabolic Reprogramming in Stroke Mice 1.00
9 8.84
Stiffness-Engineered Hydrogels Drive Neural Regeneration via the Man2b1– Lysosomal Mechanotransduction Axis 1.00
Cryo-shocked Neural Stem Cells as Factor Pool-Functionalized Nerve Guidance Conduits for Enhanced Peripheral Nerve Regeneration 1.00
Electrowritten Topographical Conduit Integrated with 4-Octyl Itaconate for Peripheral Nerve Immunomodulation and Regeneration 1.00
Microenvironment-modulating hyaluronic acid-tannic acid hydrogel for peripheral nerve injury repair 1.00
Reactive Oxygen Species-Responsive Sulfated Polysaccharide-Based Nanogels for Ischemic Stroke: A Precision Therapy through Pathological Microenvironment Modulation 1.00
Lipid nanoparticles hijack neutrophils for enhanced anti-inflammatory and stroke therapy 0.97
Super-small zwitterionic nitric oxide-donor micelles efficiently scavenge ROS and alleviate inflammation for combined ischemic stroke therapy 1.00
Discoidal nanoparticles exploit thrombus-induced shear gradients to enhance site-specific thrombolysis in stroke 1.00
Platelet membrane-camouflaged bioactive glass nano-formulations for enhanced drug delivery in the treatment of acute arterial thrombosis 0.88
20 20.00
Multi‐Scale Oriented PLCL/CNT@a Conduit Filled With Dual‐Sided Micropatterned Filaments Enhanced Peripheral Nerve Regeneration 1.00
Engineered Macrophage Microrobots Exert Precise Neuroprotection Against Ischemic Stroke by Regulating the Polarization of Inflammatory Microglia 1.00
Immuno-Training Remodeled Vascular Microenvironment via Peptide-Functionalized Hydrogel Microspheres for Neural Repair 1.00
Bioinspired Self-Curling Conduit Integrates Topography and Bioelectronics for Functional Peripheral Nerve Regeneration 1.00
Bioinspired Artificial Nociceptor Based on Quantized Conductance Memristor With Pain Rating, Self‐Healing, and Neuromodulation Capabilities 1.00
Yolk-Shell Nanoparticles with Shear Stress-Triggered Triboluminescence for Dynamic Thrombus Imaging and Tribocatalytic-Photodynamic Thrombolysis 1.00
Acid-Responsive Nanomotors Regulate the Crosstalk between Neutrophils Infiltration and Acidosis for the Precise Targeted Treatment of Ischemic Stroke 1.00
Dual-Pathway Modulated Biomimetic Conductive Hydrogel Conduit Enables Spatiotemporal Co-Delivery of Engineered C3-Exosomes and TT-10 to Potentiate Optic Nerve Regeneration 1.00
A Soft On-Skin Sensor Simultaneously Capturing Bioelectrical and Biomechanical Signals for Muscle Spasticity Detection and Assessment 1.00
Mesenchymal Stem Cell-Driven Neurotrophic Bioelectronic Platform (MSC-NBP) Potentiated Peripheral Nerve Regeneration 1.00
A Self-Curling Si3N4-Biofunctionalized Nerve Wrap for Suture-Free Peripheral Nerve Repair with Multimodal Regenerative Bioregulation 1.00
Ultrasound‐Triggered Biomimetic Piezo‐Nanoplatforms for Non‐Invasive Epilepsy Treatment 1.00
Digital Dual-Dimensional α-Synuclein Aggregate Decoding Sensor for Parkinson's Disease Diagnostics 1.00
Active Transport of Biomimetic Cascaded Nanozymes Across Blood–Brain Barrier to Scavenge ROS and Alleviate Neuroinflammation Against Cerebral Ischemia Reperfusion Injury 1.00
Microenvironment-Responsive Piezoelectric Nanofibers Antagonize Chemotherapy-Induced Peripheral Neuropathy 1.00
Surgical‐Adjuvant Hydrogel of Full‐Natural Bioactive Compounds from Chinese Medicine for Enhanced Traumatic Brain Injury Therapy by Inhibiting Complement Activation 1.00
Biodegradable Piezoelectric Amino Acid Nerve Guidance Conduit Repairs Long‐Gap Nerve Defect Under Low Frequency Vibration from Massage Gun 1.00
Biosponge-Armored Nanodots Restore Redox-Calcium Homeostasis to Mitigate Reperfusion-Induced Injury in Ischemic Stroke 1.00
Multiple‐Stimuli‐Responsive Biomimetic Polypyrrole Delivery System for Synergistic Regulation and Restoration of Epileptic Foci 1.00
Reconstruction of Joint‐Associated Peripheral Nerve Defects Using Novel Piezoelectric Spiral‐Structured Poly(Lactic Acid) Fiber Conduits: Regeneration Efficacy and Mechanistic Insights 1.00
14 13.73
Dynamic Covalent Peptide-Drug Conjugates Address the Heterogeneity in Alzheimer's Disease Progression 1.00
Synthetic Disaggregators Enhance Central-Peripheral Amyloid-β Clearance in Alzheimer's Disease 1.00
Poly(Citric Acid) Bidirectional Regulator: Coordinating Iron Homeostasis to Suppress Stress Responses and Boosting Mitochondrial Bioenergetics for Enhanced Nerve Repair 1.00
An Injectable and Modular NO‐Adaptive Delivery System for Modulating Regenerative Microenvironment in Long‐Segment Nerve Injury 1.00
A Bioinspired Force‐Inducible Hydrogel Conduit for Peripheral Nerve Regeneration 1.00
Chiral Nanoagonist Targeting EGFR for Nerve Injury Repair 0.88
NIR‐Driven Nanomotors Integrating With Platelet‐Thylakoid Hybrid Membranes for Synchronized Thrombolysis and Vascular Remodeling 1.00
Bamboo-Inspired Composite Conduit Accelerates Peripheral Nerve Regeneration through Synergistic Oriented Structure and Piezoelectricity 1.00
Multimodal Nanoregulator Rescues Impaired Neurovascular Units to Attenuate Secondary Injury Following Traumatic Brain Injury 1.00
NIR‐II Imaging‐Guided Self‐Penetrating Nanomotors for Millimeter‐Scale Deep Thrombolysis Tracking and Accelerated Embolus Clearance 1.00
Ultrasound Active Piezoelectric Nanostimulators for Long-Acting Wireless Deep Brain Electric Stimulation to Inhibit Epileptic Seizures 0.93
A Universal Strategy for BBB Transport Mediated by an Inflammatory Receptor Antagonist for Neuroprotection in Ischemic Stroke 1.00
Sonodynamic and Bioorthogonal Sonocatalytic Thrombotic Therapy Based on AIE Cationic Tetranuclear Ir(III) Complex Nanoplatform Guided by NIR‐Chemiluminescence Imaging 0.92
Carbon Quantum Dots Assisted Virus Tracking: From Skin to Brain 1.00
20 19.71
Decoding Early Neurochemical Dynamics in Circuit Dysfunction of Parkinson’s Disease via Synergetic SERS and Electrophysiological Probe Suite 1.00
Tackling the Orexin Conundrum: An Optimized LC–MS/MS Method Demonstrates Accurate CSF Quantification and Absence in Peripheral Blood 1.00
Determination of Small-Sized α‑Synuclein Oligomers Using Solid-State Nanopore Assisted with Circular Single-Stranded DNA Frame 1.00
Fluorescence Dynamics Imaging Reveals Inflammation Driven by Ferroptosis through a MAO/ONOO– Dual-Responsive Probe 0.80
Small Molecule Guided Photocatalytic Proteomics Profiling of Amyloid Deposits in Hippocampal and Cortical Alzheimer’s Disease Tissues 1.00
Simultaneous Visualization of Glutathione and Hydrogen Peroxide with a Dual-Responsive Fluorescent Probe to Elucidate Redox Homeostasis in Alzheimer’s Disease Models 1.00
Peroxynitrite-Activated Valproic Acid Precursor for Monitoring Oxidative Stress and Reducing Epileptic Seizures in an Epilepsy Model 1.00
A BBB-on-a-Chip for Ischemic Stroke Modeling: In Situ Multiparameter Monitoring with Integrated TEER and Ion Sensors 1.00
Aβ-Targeted Theranostic Agent for NIR Fluorescence Imaging Guided Type-I and Type-II Dual Photodynamic Therapy of Alzheimer’s Disease 1.00
O-Position Electronegativity Dependent Activity for Specific-Rapid Response to Superoxide Anion and Its Imaging for Epilepsy Mediated by Ferroptosis Pathway 1.00
Investigating the Effect of Oxaliplatin on Vesicular Dopamine Cargo and Release Dynamics in Brain with Single-Vesicle Electrochemistry 1.00
Near-Infrared Chemiluminescence Probe for Superoxide Anion Imaging in Alzheimer’s Disease 0.91
A Triple-Channel Fluorescent Sensor Array Based on Carbon Dots for Simultaneous Discrimination and Detection of Antiseizure Medications and Psychotropic Drugs in the Treatment of Epilepsy Comorbidities 1.00
Rational Construction of a Lipid Droplet-Targeted Redox-Responsive Ratiometric Probe for Screening of Antioxidant Drugs and Its Application in Parkinson’s Disease 1.00
In Vivo Solid-Phase Microextraction with Palladium-Doped Covalent Organic Framework-Coated Fiber for Enhanced Nicotine-Associated Metabolite Detection in Rat Brain Regions 1.00
Blood-Brain Barrier-Permeable Dual-Responsive Fluorescent Probe Reveals an Increased Risk of Alzheimer’s Disease in Diabetic Patients 1.00
A Red-Emitting Fluorescent Probe for Visualizing Hydroxyl Radical in Parkinson’s Disease and Guiding the Discovery of Methyl Ferulate for Therapeutic Intervention 1.00
Revealing the Interplay of Intraorganellar O2•– and ATP in Brain Aging-Related Alzheimer’s Disease via Unimolecular Dual-Responsive Probes 1.00
Development of Tau-441-Certified Reference Materials by Three Independent Isotope Dilution Mass Spectrometry Strategies 1.00
Activatable Proximity-Labeled Fluorogenic Probe for Visualizing the Role of Estrogen in Regulating Liver Carboxylesterase Expression 1.00
2 2.00
Effects of γ-Aminobutyric Acid and Glutamate Signalings from Primary Sensory Neurons to Gate the Spinal Transmission of Mechanical Pain in Mice. 1.00
Modulation of pain sensitivity by the locus coeruleus-paraventricular thalamic nucleus-anterior cingulate cortex pathway in mice. 1.00
6 4.63
Metal‐Organic Complex‐Engineered Artificial Metalloenzymes With Synergistic Site and Cascade ROS Elimination to Treat Cerebral Ischemic‐Reperfusion Injury 1.00
Ion‐Exchange and Energy‐Stress Strategies Amplified Dual‐Site Nanozyme‐Mediated Ferroptosis/Pyroptosis Inhibition for Neuroprotection 1.00
Two-Nanosensor Electrochemical Profiling of Catecholamine Vesicle Interactions With Acute and Chronic Stress Granules in Living Cells 0.13
Electrical Sensitive Trianthracene Nanoparticle for Afterglow Imaging Epileptic Abnormal Discharges 1.00
Cleavable Antibody‐Conjugated Aβ Specific Immune Exosome for Combination Alzheimer's Disease Immunotherapy 0.50
Thrombus Boring Microrobot Prepared by an Integrated Phase Separation and Interfacial Self‐Assembly Process Toward Thrombolysis 1.00
16 10.44
The IL-1β-STING Signaling Axis Drives Neuromyelitis Optica Pathogenesis in a Murine Model 1.00
Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion 0.49
Multimodal Image Guidance in Subthalamic Deep Brain Stimulation for Parkinson's Disease 0.11
Effects of Blood Pressure Lowering Across Hematoma Volume in Acute Intracerebral Hemorrhage: Pooled Analysis of the Four INTERACT and ATACH-2 Trials 0.37
Gelsolin‐3: A Novel Myelin Autoantigen in Demyelinating Guillain‐Barré Syndrome 0.67
Astrocytic Mitochondria Transplantation Rescues Neuron Loss and Dendritic Injuries in Acute Cerebral Ischemic Stroke Mouse Model by Flexibly Regulating Mitochondria Dynamics 1.00
Individualized Treatment in Distal and Medium Vessel Occlusion Stroke Using a Validated Explainable Counterfactual Treatment Estimation Model 0.07
Neutrophil-Secreted Enzymes and ALS Risk: Exploring a Potential Mechanistic Link 1.00
Myelitis‐Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late‐Onset Neuromyelitis Optica Spectrum Disorders 1.00
Effects of Thymectomy in Late‐Onset Myasthenia Gravis: A Multi‐Center Longitudinal Retrospective Study 1.00
Dual Antiplatelet Therapy After Ischemic Stroke Stratified by Intracranial or Extracranial Atherosclerotic Stenosis 1.00
A Distinct Immunological Signature in Late‐Onset Myasthenia Gravis: Insights from an Exploratory Proteomics Study 0.05
Brain Endothelial Soluble scpST2/scp Production and Cerebral Edema in a Rat Model of Ischemic Stroke 0.02
Adjunctive scpThrombolytics/scp After Successful Endovascular Reperfusion: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials 0.67
Sternocleidomastoid Muscle Overactivity: A Potentially Critical Contributor to Postural Abnormalities in Parkinson's Disease 1.00
Clonal Hematopoiesis of Indeterminate Potential Associated with Covert Cerebral Changes 1.00
1 0.09
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment 0.09
4 4.00
Advancing Upper Limb Motor Recovery in Acute Ischemic Stroke With Transcutaneous Auricular Vagus Nerve Stimulation 1.00
Study of the Relationships Between Gait Characteristics and Brain Function in Children With Cerebral Palsy During Walking 1.00
Characteristics of Dysphagia in Medullary and Cerebellar Stroke: An Observational Study Based on HRPM and FEES 1.00
Impact of Right Cerebellar Theta Burst Stimulation on Post-Stroke Aphasia: A Randomized Controlled Trial 1.00
13 8.00
Nav1.5 in the dorsal root ganglion plays a crucial role in mechanical hypersensitivity 0.73
Early glymphatic failure in AppNL-F knock-in mice is linked to parenchymal border macrophages loss 0.03
Loss of REST associated with Alzheimer's disease pathology is ameliorated by NAD+ 0.23
Distinct cutaneous α-synuclein signatures in body-first and brain-first Parkinson’s disease subtypes 1.00
Engineered neural stem cell vesicles activating Wnt promote blood–brain barrier repair after cerebral haemorrhage 1.00
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers 0.01
Associations between epilepsy-related polygenic risk and brain morphology in childhood 0.02
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients 0.04
iIn vivo/i self-assembled SOD1-siRNAs mitigate muscle atrophy and denervation in amyotrophic lateral sclerosis 1.00
Structural network-specific effect of extreme capsule stimulation for drug-resistant focal epilepsy 0.95
Brain regulation of pulmonary dysfunction induced by stroke 1.00
Neuropathological comorbidity, genetics and cognition in a Chinese community-based autopsy cohort 1.00
TIA1-mediated stress granules promote neurodegeneration by sequestering iHSP70/i mRNA in C9orf72 mice 1.00
2 1.03
Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses 0.03
Long-range cholinergic input promotes glioblastoma progression 1.00
7 5.32
TPPP/p25 amyloid seeding activity as a specific biomarker for multiple system atrophy 1.00
Efficient amyloid-β degradation in Alzheimer’s disease using SPYTACs 1.00
Meningeal blood vessel blockage enhances anti-glioblastoma immunity 1.00
Peripheral cancer attenuates amyloid pathology in Alzheimer’s disease via cystatin-c activation of TREM2 1.00
A glycolytic shunt via the pentose phosphate pathway is a metabolic checkpoint for nervous system sensory homeostasis and axonal regeneration 0.26
Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy 1.00
Astrocytes functionally integrate multiple synapses via specialized leaflet domains 0.06
1 1.00
Galnt2 neurons in the ventromedial hypothalamus counterregulate hypoglycemia via a brain-liver neurocircuit 1.00
4 3.17
Human retinal organoids functionally bridge a transected optic nerve in a rat model 1.00
Ferroptosis susceptibility in hippocampal neural precursor cells influences neurogenesis and memory across aging 0.17
Decoding the spatiotemporal development of the blood-brain barrier in human cortex 1.00
Human stem cell-derived A10 dopaminergic neurons specifically integrate into mouse circuits and improve depression-like behaviors 1.00
4 2.96
Dual RONS-responsive chemiluminescence-guided multimodal thrombolysis based on an aggregation-induced emission cobalt-porphyrin nanoplatform 0.92
Microfluidic-mass spectrometry analysis of blood–brain barrier transport using engineered microparticle interfaces 1.00
Amplification of magnetic field effects via critical dynamics in a nonlinear oscillatory system 1.00
Detecting alpha-synuclein aggregates with small molecules on single-molecule array 0.04
1 1.00
Apolipoprotein D, a Novel Ligand for CD36, Is Essential for Blood-Brain Barrier Integrity. 1.00
1 0.88
The p75 neurotrophin receptor controls the skeletal stem cell niche through sensory innervation 0.88
1 1.00
Increased S-adenosyl methionine strengthens the suppression in mitochondrial unfolded protein response induced by 6-PPD quinone at environmentally relevant concentrations in Caenorhabditis elegans 1.00
1 1.00
Transport of Bisphenol Analogues and Their Conjugated Metabolites Across Human Blood-Cerebrospinal Fluid Barrier 1.00
2 1.94
Dickkopf-related protein 2 impairs neurovascular Wnt signalling and worsens stroke outcome 1.00
Remote ischaemic conditioning improves outcomes of ischaemic stroke treated by endovascular thrombectomy: the SERIC-EVT trial 0.94
1 0.09
Single-nucleus multiomic profiling of the aging mouse substantia nigra reveals conserved gene alterations linked to Parkinson's disease 0.09
1 1.00
Kynurenic acid mitigates poststroke brain damage through the gut-brain neural circuit 1.00
5 3.99
Astrocytic calcium-dependent enzyme PAD2 governs microglia activity to exacerbate amyloid pathology via citrullinated vimentin 1.00
Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer’s disease risk factors 1.00
State-specific enhancer landscapes govern microglial plasticity 0.06
Cognate interaction-dependent pathogenicity of meningeal B cells drives neuroinflammation relapse 1.00
Optogenetic vagal nerve stimulation attenuates heart failure by limiting the generation f monocyte-derived inflammatory CCRL2+ macrophages 0.93
6 5.41
Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke 0.87
Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours 0.89
Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke 0.92
Intra-Arterial Alteplase After Successful Endovascular Reperfusion in Acute Stroke 0.95
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours 0.85
Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy 0.93
8 8.00
p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease 1.00
Structural basis for inhibition of the voltage-gated sodium channel NaV1.7 by the tarantula toxin HWTX-I 1.00
Downregulation of ClC-3 chloride channels in dorsal root ganglia neurons contributes to bone metastasis-induced pain 1.00
Multilineage differentiating stress-enduring cells alleviate neuropathic pain in mice through TGF-β and IL-10-dependent anti-inflammatory signaling 1.00
An extra residue in the electron transfer chain holds the key for the dual functions of an animal-like cryptochrome 1.00
The cation channel Trpa1 and chemokine Cxcl1 mediate axonal degeneration in spared nerve injury–induced neuropathic pain 1.00
Multifunctional molecular agent for tau-targeted combinational therapy of Alzheimer’s disease 1.00
Targeted degradation of α-synuclein by arginine-based PROTACs 1.00
2 2.00
Homocysteine disrupts lysosomal function by V-ATPase inhibition 1.00
SOD1 is delivered to lysosomes via autophagy to maintain lysosomal function and integrity 1.00
1 1.00
Case Series of 46 Patients With Nonketotic Hyperglycemia-associated Chorea: A Retrospective Follow-up Study 1.00
8 6.86
Aging-dependent microglial heterogeneity worsens outcomes in models of traumatic brain injury 1.00
SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington’s disease models 1.00
Inflammasome adaptor ASC promotes sustained neuroinflammation and mild cognitive impairment in a closed-head injury model 0.08
Astrocyte-intrinsic signaling of chitinase-like protein CHI3L1 drives inflammation and amplifies demyelination in neuromyelitis optica 0.83
3D cultured human medium spiny neurons functionally integrate and rescue motor deficits in Huntington’s disease mice 1.00
ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis 0.94
Cingulate retinoic acid signaling regulates neuropathic pain and comorbid anxiodepression via extracellular matrix homeostasis 1.00
Mutant THAP11 causes cerebellar neurodegeneration and triggers TREM2-mediated microglial activation in mice 1.00
1 0.02
TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation 0.02
1 0.91
Altered Diffusion Tensor Image Analysis Along the Perivascular Space in People Living with HIV: Association with Cognition and Diagnostic Utility for Asymptomatic Neurocognitive Impairment 0.91
7 5.79
COMMD1 Induces Copper Deficiency of SOD1 by Inhibiting the Palmitoylation of CCS in ALS 1.00
Targeting the HMGB1–TLR4 Axis Alleviates Neuropathic Pain-Associated Cognitive Deficits 1.00
Trigeminal motor nucleus regulates microstructure of feeding behavior without affecting total food intake 0.33
Peripheral Gating of Nociception Investigated with a Decerebrate, Arterially Perfused Preparation of the Rat 0.46
MiR-153 Prevents NRF2 Nuclear Translocation to Drive Hypoperfusion-Related Cognitive Deficits by Targeting KPNA5 1.00
IGFBP2–Ceramide Pathway Mediates Divergent Myelin Breakdown in the PNS and CNS Following Injury 1.00
Pharmacological and genetic approaches to downregulate FIS1 mitigate neuropathic pain 1.00
6 6.00
Computational Screening-Assisted Design of Bioinspired Artificial Metalloenzymes with Efficient Cascade Biocatalysis To Alleviate Cerebral Ischemia-Reperfusion Injury 1.00
Dopamine-Induced Tau Modification Prevents Pathological Phosphorylation and Generates a Distinct Fibril Polymorph 1.00
Chiral Spindle-like Nanorods Reprogram Neuroinflammation by Catalyzing α-Ketoglutarate Biosynthesis 1.00
An Engineered Supramolecular Fluorescent Chemosensor for Multiscale Visualization of Glutamate Dynamics in Living Systems 1.00
α-Synuclein Drives SNARE-Dependent Tubular Remodeling of Vesicles 1.00
C-Terminal Radical Oxidation Inhibits α-Synuclein Aggregation and Cytotoxicity via an Oxidative Oligomer-Disrupting Pathway 1.00
1 1.00
The Burden of Cardiovascular Disease in China Incidence Estimates From National Surveillance (2023) 1.00
1 0.07
Protection against ferroptosis through maintaining homeostasis of docosahexaenoate-containing phospholipids 0.07
19 17.39
Comparison of the clinical efficacy, safety and EEG functional connectivity changes between 18-Hz rTMS and iTBS of accelerated dTMS treatment for major depressive disorder: a randomized controlled trial 1.00
Cocaine facilitates Ca2+ fluctuations in prefrontal cortex astrocytes via norepinephrine transmission in awake mice 1.00
Spatial concordance metrics and related risk factors of brain-peripheral barrier axes: unveiling distinct concordance patterns for mental and neurological axes 1.00
IL-15 receptor alpha deficiency triggers depressive-like behaviors via enhanced microglial synapse pruning 0.91
Accelerated intermittent theta burst stimulation targeting personalized fronto-parietal control network improves core symptoms of autism spectrum disorder: a double-blind, randomized controlled trial 1.00
Pallidal and subthalamic stimulations modulate inter-hemispheric interaction and asymmetry in Parkinson’s disease 1.00
Tetrodotoxin-resistant NaV1.5 channels regulate excitability of lateral septum neurons and emotion behaviors of chronically stressed mice 1.00
Bidirectional association between immune-mediated diseases and major depressive disorder: evidence from cohort, genome-wide pleiotropic, and experimental studies 1.00
The anti-NMDAR1 antibodies and IL-17 signaling pathway shape NMDAR encephalitis 1.00
Meningeal macrophages alleviate social memory defects in an early Alzheimer’s disease model 1.00
Selective magnetic stimulation downregulates the GABA receptor ε subunit in the left prelimbic cortex to alleviate schizophrenia-like behaviors in mice 1.00
Connectome-based markers predict the sub-types of frontotemporal dementia 1.00
Transcranial temporal interference stimulation for treating bipolar disorder with depressive episodes: a feasibility Study 1.00
Forebrain-specific loss of erythropoietin provokes compensatory upregulation of different EPO receptors 0.05
Astrocytic Mettl14 depletion enhances cognitive function by attenuating astrogliosis via the DUSP1/MAPK pathway in APP/PS1 mice: targeting neuroinflammation in Alzheimer’s disease 1.00
Estrogen receptor beta in lateral habenula mediates antidepressant effects of estrogen in postpartum-hormone-withdrawal-induced depression 1.00
The NMDAR/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer’s disease 0.43
Efficacy and safety of transcutaneous auricular vagus nerve stimulation for patients with treatment-resistant schizophrenia with predominantly negative symptoms: a randomized clinical trial and efficacy sensitivity biomarkers 1.00
Plasma neurofilament light reflects more severe manifestation of Alzheimer’s disease in men 1.00
2 2.00
Simultaneous Profiling and Quantification of Tau and Its Phosphorylated Isomers Using Engineered FraC Nanopores 1.00
Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy 1.00
5 2.98
Long-term thrombus-free left atrial appendage occlusion via magnetofluids 1.00
Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease 0.13
Parkinson’s disease as a somato-cognitive action network disorder 0.74
Ageing promotes microglial accumulation of slow-degrading synaptic proteins 0.12
Structural and functional characterization of human sweet taste receptor 1.00
1 0.87
Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer’s brains 0.87
2 1.85
ALDH2-mediated GABA biosynthesis regulates hippocampal LTP and learning adaptability 0.85
Pharmacological inhibition of PSPH reduces serine levels and epileptic seizures 1.00
60 44.38
OFC-induced network modularity improves positive symptoms and attentional alertness in schizophrenia: a combined rTMS-fMRI study 0.75
An implantable mechano-electro cascade platform synchronizes neuro-muscle repair 1.00
Dual activation of MC3R and MC4R drives weight loss and reduces food intake in male primates with obesity 0.08
Single-nucleus analysis reveals human-specific oligodendrocyte polarization and conserved neuronal responses after severe traumatic brain injury 0.91
Substrate recognition and allosteric inhibition of human betaine/GABA transporter 1 1.00
elective and differential roles of PVHCRH neurotransmitters in diet-induced obesity in mice 0.07
Tumor-derived GDF15 induces CCN3⁺ Schwann cells to promote cancer pain in pancreatic cancer 1.00
Structural basis for the transport mechanism and cholesterol modulation of the human proline transporter 1.00
Auricular vagus nerve stimulation drives analgesia via an auricle–brain axis in a mouse model of neuropathic pain 1.00
Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial 1.00
A midbrain circuit for high-fat-food induced conditioned taste aversion 1.00
Perirhinal cortex gains control of hippocampal seizures via broad downstream circuits in male mouse models 1.00
Transport and inhibition mechanisms of human glycine transporter 2 1.00
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality 0.05
Dysregulation of macrophage lipid metabolism underlies intracellular bacterial neuroinvasion 0.98
TOX3 in hypothalamic POMC-lineage cells regulates energy balance via the PTEN-AKT signaling axis 1.00
ASO therapy rescues NOTCH2NLC GGC repeat expansion-induced genomic damage, 3D chromatin structural abnormalities, and senescence 0.96
Distinct modes of dopamine modulation on striatopallidal synaptic transmission 0.07
Dual-stiffness nanoparticles for compartment-specific drug delivery in stroke 0.94
Alzheimer’s Aβ catalyzes Tau phase separation and aggregation via early nanocluster solubilization 0.20
Cerebrospinal fluid NPTX1 and NPTXR predict neurodegeneration and clinical progression in Alzheimer’s disease 0.69
Gut microbiota-dependent 24-hydroxycholesterol metabolism contributes to capsaicin-induced amelioration of Alzheimer’s disease-like pathology in mice 1.00
MerTK-triggered TGFβ1 autocrine signal regulates microglial response to neurodegeneration 1.00
A spatiotemporal atlas of cerebrovascular development in zebrafish 1.00
The E3 ligases Itch and WWP2 regulate autoimmune neuroinflammation by controlling T2 to T17 cell conversion via interleukin-4-STAT5 axis in mice 1.00
Spatial heterogeneity and subtypes of functional connectivity development in youth 0.08
Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy 0.87
Precise excision of expanded GGC repeats in NOTCH2NLC via CRISPR/Cas9 for treating neuronal intranuclear inclusion disease 1.00
Closed-loop wearable neurostimulation system with triboelectric sensing to alleviate hemifacial spasms 1.00
SigmaR1 is an auxiliary translocon factor with lipid-binding activity that regulates protein and lipid droplet homeostasis 1.00
High-fat diet disrupts a septal control on feeding to promote obesity in male mice 1.00
The gut vagal sensory pathway drives postprandial sleep via activation of PVH-projecting GABAergic neurons in the NTS 1.00
Transferrin-phosphatidylserine liposomes target TDP-43 and neuroinflammation in male mice with neuropathic pain 1.00
NMDA receptors coordinate brain vascular development via neuron-to-endothelial tip cell crosstalk in zebrafish 1.00
Aberrant adenosine A2A receptor signaling in the choroid plexus drives CSF hypersecretion and ventriculomegaly in hydrocephalus 0.94
Aberrant neural activity in the peritumoral cortex underlies the progression of tumor-associated seizures 0.15
ZFP612 controls neuropathic pain through epigenetic repression of within the silencer–promoter loop in primary sensory neurons of male mice 0.93
Perimenopausal state oestradiol to progesterone imbalance drives Alzheimer’s risk via ERRα dysregulation and energy dyshomeostasis 0.71
Sox9 regulation of hexokinase 1 controls neuroinflammatory astrocyte subtypes in a rat model of neuropathic pain 1.00
Migration of CD8 + TSCM cells into intestine via PPBP–CXCR2 axis increases host stress susceptibility by inhibiting gut microbiome-derived homovanillic acid 0.94
Personalized biomarkers of multiscale functional alterations in temporal lobe epilepsy 0.04
Prefrontal–bed nucleus of the stria terminalis physiological and neuropsychological biomarkers predict therapeutic outcomes in depression 0.79
DISC1 Protects Against Zika Virus Infection and Long-Term Neurological Damage Through AMPK-mTOR-Mediated Autophagy 1.00
Platelet activation plays a pro-inflammatory role in myasthenia gravis 1.00
Munc13-1 restoration mitigates presynaptic pathology in spinal muscular atrophy 0.06
A wireless optogenetic stimulation system for long-term function evaluation of mice forelimb with sub-nerve resolution 0.92
Brain–cervical lymph node crosstalk contributes to brain injury induced by subarachnoid hemorrhage in mice 0.93
Gut microbial production of imidazole propionate drives Parkinson’s pathologies 0.11
Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer’s disease mouse model 0.02
CSF total tau as a proxy of synaptic degeneration 0.01
Design of Ig-like binders targeting α-synuclein fibril for mitigating its pathological activities 1.00
SERBP1-PCIF1 complex-controlled m6Am modification in glutamatergic neurons of the primary somatosensory cortex is required for neuropathic pain in mice 0.94
Mechanically robust neuroprotective stent by sequential Mg ions release for ischemic stroke therapy 0.90
Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease 0.53
Targeting modulation of the choroid plexus blood-CSF barrier and CSF hypersecretion via lipid nanoparticle-mediated co-delivery of siRNA and resveratrol 1.00
SEMA3B switches axon-axon to axon-glia interactions required for unmyelinated axon envelopment and integrity 0.92
Brain-wide input-output analysis of tuberal nucleus somatostatin neurons reveals hierarchical circuits for orchestrating feeding behavior 0.33
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease 0.01
Reduction of neuronal activity mediated by blood-vessel regression in the adult brain 0.58
Atlas of Proteomic signatures of brain structure and its links to brain disorders 0.95
1 0.01
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis 0.01
1 0.82
Population attributable fractions of a wide range of peripheral diseases for the burden of dementia 0.82
1 0.03
Monocyte infiltration induces CNS arginine catabolism to fuel neuroinflammation 0.03
1 0.04
Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial 0.04
8 4.55
Tau aggregates cause reactivation of transposable DNA elements, leading to Z-RNA–ZBP1-mediated neuronal death 1.00
Circuit response to neuromodulation characterized with simultaneous deep brain stimulation and precision neuroimaging in humans 0.95
Bright light exposure suppresses feeding and weight gain via a visual circuit linked to the lateral hypothalamus 1.00
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease 0.01
Differential synaptic depression mediates the therapeutic effect of deep brain stimulation 0.13
Astrocytic Ca2+ prevents synaptic depotentiation by limiting repetitive activity in dendrites during motor learning 0.50
A bottom-up septal inhibitory circuit mediates anticipatory control of drinking 0.93
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
17 15.23
Astrocyte cell volume dynamics across cortical states and transitions 0.51
A reciprocal glial circuit calibrates injury information and governs the tissue response balance 0.64
Targeting PGAM5-driven mitochondrial integrated stress response slows ALS progression across subtypes 1.00
Astrocytic H3 receptors regulate anxiety through GABA signaling 1.00
CB1R and GlyT2 interaction in spinal glycinergic circuits drives neuropathic mechanical pain 1.00
Gut-brain cholinergic signaling mediates the antiseizure effects of Bacteroides fragilis 0.96
Biased histamine signaling selectively gates fat preference 1.00
C5aR1+ microglia exacerbate neuroinflammation and cerebral edema in acute brain injury 1.00
BST2 expression at astrocyte borders promotes microglial recruitment via the C3/C3aR signaling 1.00
Lcn2 from neutrophil extracellular traps induces astrogliosis and post-stroke emotional disorders 0.94
Segregated supramammillary-dentate gyrus circuits modulate cognitive and affective function in healthy and Alzheimer’s disease model mice 0.52
Astrocyte-mediated central amygdala microcircuit gates comorbid anxiety symptoms in chronic pain 1.00
Identification of a neural basis for energy expenditure in the mouse arcuate hypothalamus 1.00
Neural basis of transcutaneous electrical nerve stimulation for neuropathic pain relief 1.00
Optimized deep brain stimulation for anterior cingulate cortex inhibition produces antidepressant-like effects in mice 1.00
In vivo 7 Tesla MRI of non-human primate intracortical microvascular architecture 0.67
Spatiotemporal transcriptomic maps of mouse intracerebral hemorrhage at single-cell resolution 1.00
3 2.69
Ischemic stroke triggers brain-wide synaptic remodeling within four hours 0.69
RIN1 regulates developmental and pain-related plasticity in spinal synapses via NMDA receptor subunit trafficking 1.00
Environmental noise-induced changes to the IC-SNc circuit promotes motor deficits and neuronal vulnerability in a mouse model of Parkinson’s Disease 1.00
3 2.06
Association between gabapentinoid treatment, concurrent use with opioid or benzodiazepine and the risk of drug poisoning: A self-controlled case series study 0.18
Deep brain stimulation surgical timing, outcomes, and prognostic factors in patients with Parkinson’s disease: A Chinese retrospective multicenter cohort study 0.88
Intra-arterial selective hypothermia for acute ischemic stroke neuroprotection: A multicenter pilot trial in China 1.00
25 18.68
Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model 0.98
Fatty acid regulation of feeding in Caenorhabditis elegans reveals the potential ancestral origin of a GLP-1-like multiagonist signaling system 0.02
DIRAS2 modulates MAPK pathway–mediated ferroptosis to regulate excitation/inhibition balance and seizure susceptibility 1.00
GFAP+ FOXF2+ ependymal cells promote blood–brain barrier repair via DLL4–NOTCH signaling after neural injury 1.00
ATP13A2 restrains macrophage NLRP3 inflammasome activation to repress neurodegeneration via modulating mitochondrial homeostasis 0.98
Reversibility and β-sheet formation are decoupled in tau condensate aging 0.18
Substance P in the lateral hypothalamic area regulates binge‐like eating behaviors in mice 1.00
Natalizumab exacerbates astrocytopathy in NMOSD via blockade of endothelial VCAM1–astrocytic integrin α4 interaction 1.00
Microvascular architecture and physiological fluctuations constrain the control of cerebral microcirculation 0.60
Hyperglycemia promotes SIRT3-mediated deacetylation of SARM1 to exacerbate diabetic peripheral neuropathy in mice 1.00
Highly sensitive chemiluminescence imaging of misfolded proteins in neurodegenerative models 0.13
USP25 inhibition ameliorates Parkinson’s disease by restoring mitophagy 1.00
Long-term effects of forty-hertz auditory stimulation as a treatment of Alzheimer’s disease: Insights from an aged monkey model study 0.98
Structural insights into human signal peptide peptidase 1.00
Galectin-related protein, a key contributor, drives diabetes-associated neuropathic pain 1.00
Mechanisms of transport and analgesic compounds recognition by glycine transporter 2 1.00
Geometrical compartmentalization of trigger waves 0.20
Microglia contribute to bipolar depression through Serinc2-dependent phospholipid synthesis 1.00
Amyloid β–dependent neuronal silencing through synaptic decoupling 0.12
Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm 1.00
Targeting PBK with small-molecule 1-O-acetyl-4R,6S-britannilactone for the treatment of neuroinflammation 0.78
Molecular basis for substrate recognition and transport of mammalian taurine transporters 1.00
Vamp3/syntaxin 4 mediates the basolateral membrane fusion of TfR transcytosis across the BBB and is exploited by pathogenic Escherichia coli 0.67
Multiomics integration prioritizes potential drug targets for multiple sclerosis 0.04
Intermediate light adaptation induces oscillatory phototaxis switching and pattern formation in Chlamydomonas 1.00
10 8.44
Simultaneous Brain Iron and α-Synuclein Detection in Patients with Synucleinopathies via Quantitative Susceptibility Mapping MRI. 1.00
Evaluation of Tibial Nerve Microcirculation in Diabetes Mellitus at Superresolution US. 1.00
Endovascular Therapy versus Medical Management for Basilar Artery Occlusion Presenting beyond 24 Hours. 0.79
Endovascular Recanalization versus Medical Treatment Alone for Symptomatic Nonacute Intracranial Artery Occlusion: A Multicenter Cohort Study. 1.00
Statins Reduce Wall Enhancement at Vessel Wall MRI in Unruptured Vertebrobasilar Dissecting Aneurysms: A Randomized Controlled Trial. 0.86
Therapeutic Efficacy of Endovascular Thrombectomy in Acute Basilar Artery Occlusion with Mild Symptoms. 1.00
Endovascular Thrombectomy versus Standard Medical Management in Treatment of Acute Medium Vessel Occlusion Strokes: A Multicenter Registry. 0.75
Microstructural Bias in the Assessment of Periventricular Flow as Revealed in Postmortem Brains. 1.00
Quantitative Ultrashort Echo Time MRI for Evaluation of Sciatic Nerve Degeneration and Regeneration in Rat Models. 0.04
Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis without Adjacent Branch Atheromatous Disease: A Randomized Trial with Patients Selected by Using Three-Dimensional Rotational Angiography. 1.00
3 1.78
Luminal surface proteome of the brain vasculature uncovers blood-brain barrier regulators 0.10
Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration 0.68
Microglia replacement halts the progression of microgliopathy in mice and humans 1.00
18 14.68
Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson’s disease 1.00
Directional guidance to orient Schwann cell alignment in nerve regeneration requires Plexin-B1 0.20
Selective vulnerability of cerebral vasculature to NOTCH3 variants in small vessel disease and rescue by phosphodiesterase-5 inhibitor 0.21
Self-inactivating AAV-CRISPR at different ages enables sustained amelioration of Huntington’s disease deficits in BAC226Q mice 1.00
Inflamed vessel–anchored release of H2 across the blood-brain barrier for ischemic stroke neuroprotection 1.00
In situ coagulation environment regulation–assisted thrombus clearance via hydrogenated silicon-based nanothrombolytics 1.00
Neuroimmune activation in temporal lobe epilepsy patients with worsening seizure following the COVID-19 pandemic: A [18F]DPA-714 PET/MR study 1.00
GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and behavioral abnormalities in Mecp2 and Disc1 transgenic mice 0.42
BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares 1.00
Neurexin regulates mechanical nociceptive sensitization by central inhibition in Drosophila 1.00
Brainstem circuit for sickness-induced sleep 0.13
Down-regulation of gastrin-releasing peptide in medial orbitofrontal cortex to nucleus accumbens projections contributes to allodynia and negative affect 1.00
Multidimensional dynamic optical imaging unveils anesthetic-driven hemispheric lateralization in blood-brain barrier homeostasis 1.00
DKK3-LRP1 complex and a chemical inhibitor regulate Aβ clearance in models of Alzheimer’s disease 0.71
Chaperone nanomotors with chemotactic ability for the treatment of Parkinson’s disease 1.00
Precise rewiring of corticospinal axons and spinal interneurons via near-infrared optogenetics for spinal cord injury treatment 1.00
Neuronal Reg3β/macrophage TNF-α–mediated positive feedback signaling contributes to pain chronicity in a rat model of CRPS-I 1.00
Synthetic efferocytic receptor microglia enhances anti-inflammatory clearance of amyloid-β for AD treatment in mice 1.00
2 2.00
Targeting brain hubs of ictal fast ripple activity to reduce seizures in patients with drug-resistant epilepsy 1.00
Microglial pruning of glycinergic synapses disinhibits spinal PKCγ interneurons to drive pain hypersensitivity in mice 1.00
2 1.91
Accelerated continuous theta burst stimulation targeting left primary motor cortex for children with autism spectrum disorder: multicentre randomised sham controlled trial 0.91
Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial 1.00
2 0.09
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2 0.04
Optochemical profiling of NMDAR molecular diversity at synaptic and extrasynaptic sites. 0.05
2 2.00
Elucidation of Structural Fluctuation for Initial Signaling and DNA Recognition for Damage Repair of a Bifunctional Cryptochrome 1.00
Alternative Photoreduction Pathway Involving Electron Tunneling and Proton Transfer in a Bifunctional Cryptochrome 1.00
3 1.78
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication 0.11
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial 0.85
Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial 0.82
2 0.39
Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study 0.05
Effects of blood pressure lowering in relation to time in acute intracerebral haemorrhage: a pooled analysis of the four INTERACT trials 0.34
4 1.85
Endovascular Treatment of Medium-Vessel-Occlusion Strokes 0.86
Asundexian for Secondary Stroke Prevention 0.02
Risdiplam in Presymptomatic Spinal Muscular Atrophy 0.05
Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke 0.92

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.